Proliferative Diabetic Retinopathy (pdr) Clinical Trials
2 recruiting trials for Proliferative Diabetic Retinopathy (pdr). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Proliferative Diabetic Retinopathy (pdr) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Xiamen Ophthalmology Center Affiliated to Xiamen University (1), Jaeb Center for Health Research (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Microincision Vitrectomy Surgery (procedure, 1 trial), followed by Panretinal Photocoagulation, Vitrectomy.
Track Proliferative Diabetic Retinopathy (pdr) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
The goal of this clinical trial is to learn whether early microincision vitrectomy surgery (MIVS) can improve retinal neovascularization outcomes compared to standard pan-retinal...
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combination a of faricimab + PRP or...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Proliferative Diabetic Retinopathy (pdr), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Proliferative Diabetic Retinopathy (pdr), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Proliferative Diabetic Retinopathy (pdr), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.